Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) CFO Fawwad Qureshi sold 4,645 shares of Trupanion stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $25.61, for a total value of $118,958.45. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.
Trupanion Stock Performance
TRUP traded down $0.70 during trading on Friday, hitting $26.54. 372,424 shares of the company traded hands, compared to its average volume of 617,031. Trupanion, Inc. has a one year low of $25.24 and a one year high of $57.88. The stock’s fifty day moving average is $32.95 and its 200 day moving average is $38.69. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.27. The firm has a market cap of $1.15 billion, a P/E ratio of 58.98 and a beta of 1.58.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings data on Thursday, February 12th. The financial services provider reported $0.13 EPS for the quarter, missing the consensus estimate of $0.14 by ($0.01). Trupanion had a return on equity of 5.39% and a net margin of 1.35%.The company had revenue of $376.85 million during the quarter, compared to the consensus estimate of $375.89 million. During the same period in the prior year, the firm posted $0.04 EPS. The business’s revenue was up 11.7% on a year-over-year basis. As a group, equities analysts predict that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.
Institutional Investors Weigh In On Trupanion
Wall Street Analysts Forecast Growth
TRUP has been the topic of several research reports. Weiss Ratings upgraded Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, February 17th. Wall Street Zen cut Trupanion from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. Stifel Nicolaus dropped their price objective on shares of Trupanion from $38.00 to $35.00 and set a “hold” rating on the stock in a report on Friday, February 13th. Cantor Fitzgerald reduced their target price on shares of Trupanion from $50.00 to $42.00 and set a “neutral” rating for the company in a research note on Wednesday, January 14th. Finally, Piper Sandler lowered their price target on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating on the stock in a research report on Friday, February 13th. Two investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $45.50.
View Our Latest Research Report on TRUP
About Trupanion
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Featured Articles
- Five stocks we like better than Trupanion
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
